GE Medical Systems and echelon Sign an Exclusive Agreement
to Provide Online Education through PETech Series
ORLANDO, Fla. - GE Medical Systems and echelon, a division of Florida Hospital College, today announced at the inaugural Academy of Molecular Imaging show an exclusive agreement to develop, administer, and market ongoing online educational programs through the PETech Series, a worldwide offering available exclusively through GE Medical. These revolutionary educational offerings will meet current and future customer needs for enhanced understanding of positron emission tomography (PET) technology and its clinical applications.
"We are pleased to enable this online educational opportunity for PET technologists around the world,” said Dow Wilson, Global General Manager of Functional and Molecular Imaging for GE Medical Systems. “By providing physicians with well-trained technologists, productivity will be improved through increased throughput, reduced patient wait time, and ultimately better images and studies for physicians’ use in diagnosis.”
The PETech Series’ blended delivery format combines web-based modules with intensive in-residence training to provide continuing education credits to those who take the course. The first PETech Series will take place in February 2002.
“We welcome the partnership with GE Medical Systems to provide quality learning experiences for nuclear medicine technologists,” said Dr. David E. Greenlaw, President and CEO of Florida Hospital College of Health Sciences. “The PETech Series will offer the Nuclear Medicine Technologists several hours of online education and multi-day onsite ‘shadowing’ experience at Florida Hospital in Orlando, Florida, one of GE Medical’s premier PET installation sites. We are confident that our blended learning approach will provide technologists the expertise they need to give the patient the best care possible.”
This agreement will leverage GE Medical’s leadership in PET technology and applications with echelon’s expertise in educational design and delivery.
“Physicians tell us that the PETech Series fills a void in PET education, by providing a unique opportunity for nuclear medicine technologists to enhance their knowledge by attending a certified PET program,” said Wilson. “Furthermore, the PETech Series provides online access to PET educational material, exposure to the latest clinical applications, and networking opportunities with other members of the PET community.”
About echelon echelon, in connection with Florida Hospital College of Health Sciences, is fast becoming one of the premier providers of distance learning for the medical community. It is pursuing relationships that will enhance its ability to deliver information that is timely, relevant and cost-effective. These educational opportunities are strictly designed to be media rich, highly interactive and educationally sound. More information about echelon can be found at www.echeloned.com.
About GE Medical Systems
GE Medical Systems is an $8 billion global leader in medical information and technology. Its offerings include networking and productivity tools, healthcare information systems, patient monitoring systems, conventional and digital X-ray, computed tomography (CT), magnetic resonance (MR), ultrasound and bone mineral densitometry, positron emission tomography (PET), and nuclear medicine. For more than 100 years, health care providers worldwide have relied on GE Medical Systems for high quality medical technology, services and productivity solutions. For more information, visit the GE Medical Systems Web site at gemedicalsystems.com.
Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. echelon and the General Electric Company caution that there can be no assurance that actual results or conditions will not differ materially from those projected or suggested in such forward-looking statements based on a variety of factors, including, but not limited to, the companies’ early stages of development, product developments risks, uncertainty of additional funding, competition, reliance on a few customers, and the companies’ abilities to protect their patents and proprietary rights and commercialize their products. echelon and GE disclaim any intent or obligation to update these forward-looking statements.
By using our site or downloading materials from the site, you agree to our Privacy Policy and Terms of Use. Click above to review those policies. If you do not agree, do not use the site or download any materials from it.
